Is the ross procedure a suitable choice for aortic valve replacement in children with rheumatic aortic valve disease?

Bahaaldin Alsoufi1, Cedric Manlhiot, Bahaa Fadel

  • 1King Faisal Heart Institute, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Insights

The Ross procedure offers excellent survival for children with rheumatic fever, but aortic regurgitation necessitates frequent autograft reoperation. Improved patient selection and surgical techniques can reduce reoperation rates.

Area of Science:

  • Pediatric Cardiac Surgery
  • Aortic Valve Replacement
  • Rheumatic Heart Disease

Background:

  • The Ross procedure is a preferred aortic valve replacement in pediatric patients.
  • Concerns exist regarding late autograft reoperation due to dilatation and regurgitation after the Ross procedure.
  • Suitability of the Ross procedure in children with rheumatic fever requires investigation.

Purpose of the Study:

  • To evaluate the long-term outcomes of the Ross procedure in children with rheumatic fever.
  • To determine the incidence and risk factors for autograft reoperation and death.
  • To assess freedom from aortic regurgitation and need for homograft or any cardiac reoperation.

Main Methods:

  • Retrospective review of medical records for 104 children with rheumatic fever who underwent the Ross procedure (1991-2004).
  • Application of competing risks methodology to analyze time-related prevalence of reoperation and death.
  • Identification of associated risk factors for adverse outcomes.

Main Results:

  • Ten-year survival was excellent (1% mortality), but 32% required autograft reoperation.
  • Freedom from moderate or severe aortic regurgitation at 10 years was 63%.
  • Freedom from autograft reoperation was lower for regurgitation (65%) than stenosis (90%); earlier surgery year and lack of annular stabilization were risk factors.

Conclusions:

  • The Ross procedure in children with rheumatic fever demonstrates excellent survival but is challenged by significant aortic regurgitation and high rates of autograft reoperation.
  • Preoperative regurgitation, concomitant surgery, and earlier surgical era are identified risk factors for autograft reoperation.
  • Enhanced patient selection and refined surgical techniques, including root and sinotubular stabilization, are crucial for improving long-term outcomes and reducing reoperation rates.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...